{"id":59147,"name":"THE LIVINGSTON GROUP, LLC OBO INNOVATIVE VACCINE TECHNOLOGIES","slug":"the-livingston-group-llc-obo-innovative-vaccine-technologies","state":"DC","country":"United States of America","description":"Consulting/lobbying firm","totalSpending":50000,"filings":9,"yearlySpending":[{"year":2024,"income":40000},{"year":2025,"income":10000}],"issues":[{"code":"DEF","display":"Defense"}],"firms":["OCULUS STRATEGIES, LLC"],"lobbyists":["CHRISTOPHER CARON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["H.R. 4365, FY25 Defense Appropriations Act, RDT&E Title; S.2587 Senate FY25 Defense Appropriations Act, RDT&E Title; synthetic vaccine","FY2024 and FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev.","FY2024 and FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev.","H>8774 and S 4921, FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev.","H>8774 and S 4921, FY2025 Defense Appropriations Act, RDT&E Title for vaccine product dev."]}